Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides
Nucleic Acids Research · 09.06.2023 · 51 (10) · 4713-4725
DOI: 10.1093/nar/gkad309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 26.04.2023. Verfasst von Vito Genna und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mechanisms of Diseases, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-1…. Hauptthemen laut MEDLINE: Phosphorothioate Oligonucleotides, Oligonucleotides, Antisense. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Molecular Biology Organization, Juan de la Cierva-INCORPORACIÓN, Spanish Ministry of Science.
Abstract (Originalsprache)
Phosphorothioates (PS) have proven their effectiveness in the area of therapeutic oligonucleotides with applications spanning from cancer treatment to neurodegenerative disorders. Initially, PS substitution was introduced for the antisense oligonucleotides (PS ASOs) because it confers an increased nuclease resistance meanwhile ameliorates cellular uptake and in-vivo bioavailability. Thus, PS oligonucleotides have been elevated to a fundamental asset in the realm of gene silencing therapeutic methodologies. But, despite their wide use, little is known on the possibly different structural changes PS-substitutions may provoke in DNA·RNA hybrids. Additionally, scarce information and significant controversy exists on the role of phosphorothioate chirality in modulating PS properties. Here, through comprehensive computational investigations and experimental measurements, we shed light on the impact of PS chirality in DNA-based antisense oligonucleotides; how the different phosphorothioate diastereomers impact DNA topology, stability and flexibility to ultimately disclose pro-Sp S and pro-Rp S roles at the catalytic core of DNA Exonuclease and Human Ribonuclease H; two major obstacles in ASOs-based therapies. Altogether, our results provide full-atom and mechanistic insights on the structural aberrations PS-substitutions provoke and explain the origin of nuclease resistance PS-linkages confer to DNA·RNA hybrids; crucial information to improve current ASOs-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mechanisms of Diseases, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona 08028, Spain.
- NBD | Nostrum Biodiscovery, Baldiri Reixac 10, Barcelona 08028, Spain.
- Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
- Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA.
- Instituto de Química Física Rocasolano, C/ Serrano 119, Madrid 28006, Spain.
- Department of Inorganic and Organic Chemistry, Section of Organic Chemistry, IBUB, University of Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain.
ORCID-Profile: Vito Genna, Carlos González
Förderung
- European Molecular Biology Organization
- Juan de la Cierva-INCORPORACIÓN
- Spanish Ministry of Science
- Catalan Government AGAUR
- Instituto de Salud Carlos III
- Fondo Europeo de Desarrollo Regional
- H2020 European Commission
- MINECO Severo Ochoa Award of Excellence from the Government of Spain
Zitieren
APA
Genna, V., Iglesias-Fernández, J., Reyes-Fraile, L., Villegas, N., Guckian, K., Seth, P., Wan, B., Cabrero, C., Terrazas, M., Brun-Heath, I., González, C., Sciabola, S., Villalobos, A., & Orozco, M. (2023). Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides. Nucleic Acids Research, 51(10), 4713-4725. https://doi.org/10.1093/nar/gkad309
Vancouver
Genna V, Iglesias-Fernández J, Reyes-Fraile L, Villegas N, Guckian K, Seth P, et al. Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides. Nucleic Acids Research. 2023;51(10):4713-4725. doi:10.1093/nar/gkad309
BibTeX
@article{Genna2023,
author = {Genna, Vito and Iglesias-Fernández, Javier and Reyes-Fraile, Laura and Villegas, Nuria and Guckian, Kevin and Seth, Punit and Wan, Brad and Cabrero, Cristina and Terrazas, Montserrat and Brun-Heath, Isabelle and González, Carlos and Sciabola, Simone and Villalobos, Anabella and Orozco, Modesto},
title = {Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {10},
pages = {4713--4725},
doi = {10.1093/nar/gkad309}
}
EUVIMED